Pharmaceutical and medicine manufacturing R&D funded by other external sources
Cost of research and development performed by pharmaceutical and medicine manufacturing companies that was paid for by other external organizations.
Unit million USD Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Pharmaceutical and medicine manufacturing R&D funded by other external sources
United States, 2023
Every record
All records
1 record · 1 region · 2023
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Business R&D Performance in the United States Increases to $722 Billion in 2023 | NCSES | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Pharmaceutical and medicine manufacturing R&D funded by other external sources. Retrieved from https://statorigin.org/indicators/pharmaceutical-and-medicine-manufacturing-r-d-funded-by-other-external-sources